TELPLUS TRIO HS

About

TELPLUS TRIO HS is a comprehensive fixed-dose combination medication engineered to provide robust and sustained blood pressure control by simultaneously targeting three distinct physiological pathways involved in hypertension. This formulation typically integrates Telmisartan, an angiotensin II receptor blocker (ARB), Amlodipine, a dihydropyridine calcium channel blocker, and Hydrochlorothiazide, a thiazide diuretic. Telmisartan effectively blocks the vasoconstrictive and aldosterone-secreting effects of angiotensin II. Amlodipine induces peripheral vasodilation by inhibiting the influx of calcium ions into vascular smooth muscle cells. Hydrochlorothiazide promotes the excretion of sodium and water by the kidneys, thereby reducing extracellular fluid volume and cardiac preload. The synergistic action of these three agents leads to a profound reduction in blood pressure, making it particularly suitable for patients with moderate to severe essential hypertension whose blood pressure is not adequately managed by monotherapy or dual therapy, offering enhanced efficacy and improved patient adherence through a single-pill regimen.

Uses

• Treatment of essential hypertension.
• Management of high blood pressure in patients requiring multiple agents.
• Reduction of cardiovascular risk in hypertensive patients.
• When monotherapy or dual therapy is insufficient.

Directions For Use

Take orally once daily, preferably at the same time each day, with or without food, as directed by your doctor.

Benefits

• Potent and sustained blood pressure reduction.
• Combines three distinct mechanisms of action.
• Improved patient compliance due to single pill.
• Effective for resistant hypertension.
• Reduces overall cardiovascular burden.
• Provides comprehensive blood pressure control.

Side Effects

• Dizziness
• Headache
• Peripheral edema (Amlodipine)
• Fatigue
• Nausea
• Hypotension
• Hyperkalemia (Telmisartan)
• Hypokalemia (Hydrochlorothiazide)
• Muscle cramps
• Increased urination
• Cough
• Rash

Safety Measures

• Alcohol - Limit alcohol intake as it can enhance the hypotensive effects and increase risk of dizziness.
• Pregnancy - Contraindicated during the second and third trimesters due to risk of fetal harm from Telmisartan.
• Breastfeeding - Not recommended; components may pass into breast milk and potentially harm the infant.
• Liver - Use with caution in patients with severe hepatic impairment; dosage adjustments may be necessary.
• Kidney - Use with caution in patients with severe renal impairment; monitor kidney function and electrolytes closely.
• Lung - Generally safe for use in patients with lung conditions; no specific contraindications related to lung function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.